Published in J Med Genet on April 01, 2005
Building a brain in the gut: development of the enteric nervous system. Clin Genet (2012) 1.21
Pathways systematically associated to Hirschsprung's disease. Orphanet J Rare Dis (2013) 0.90
A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3. J Med Genet (2006) 0.88
A novel study of copy number variations in Hirschsprung disease using the multiple ligation-dependent probe amplification (MLPA) technique. BMC Med Genet (2009) 0.87
Comprehensive analysis of RET common and rare variants in a series of Spanish Hirschsprung patients confirms a synergistic effect of both kinds of events. BMC Med Genet (2011) 0.86
Mutational spectrum of semaphorin 3A and semaphorin 3D genes in Spanish Hirschsprung patients. PLoS One (2013) 0.84
Fine mapping of the 9q31 Hirschsprung's disease locus. Hum Genet (2010) 0.83
Comprehensive analysis of NRG1 common and rare variants in Hirschsprung patients. PLoS One (2012) 0.83
Novel association of severe neonatal encephalopathy and Hirschsprung disease in a male with a duplication at the Xq28 region. BMC Med Genet (2010) 0.82
RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease. PLoS One (2014) 0.79
Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients. PLoS One (2013) 0.79
A new experimental approach is required in the molecular analysis of intestinal neuronal dysplasia type B patients. Exp Ther Med (2010) 0.76
Advances in understanding functional variations in the Hirschsprung disease spectrum (variant Hirschsprung disease). Pediatr Surg Int (2016) 0.75
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst (2000) 16.92
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet (1997) 10.71
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol (2000) 6.40
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (1995) 6.16
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (1993) 5.81
Is secondary haemorrhage after tonsillectomy in adults an infective condition? Objective measures of infection in a prospective cohort. Clin Otolaryngol (2007) 5.45
Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust (1999) 5.40
Context, composition and heterogeneity: using multilevel models in health research. Soc Sci Med (1998) 5.35
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A (1997) 5.32
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
A molecular technique for identification of bacteria using small subunit ribosomal RNA sequences. Biotechniques (1994) 4.73
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet (2001) 4.71
MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology (2002) 4.67
Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet (1997) 4.39
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
Complete transformation by adenovirus 2 requires both E1A proteins. Cell (1984) 3.80
Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc (2001) 3.62
Preclinical prediction of Alzheimer's disease using SPECT. Neurology (1998) 3.60
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension (1990) 3.30
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22
Asthma care in general practice--time for revolution? Br J Gen Pract (1991) 2.93
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol (1999) 2.79
Smoking and deprivation: are there neighbourhood effects? Soc Sci Med (1999) 2.79
Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet (2001) 2.77
Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth (2000) 2.75
Measurement of systemic oxygen uptake during low-flow anaesthesia with a standard technique vs. a novel method. Anaesthesia (2002) 2.73
Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell (1999) 2.71
Smaller inner ear sensory epithelia in Neurog 1 null mice are related to earlier hair cell cycle exit. Dev Dyn (2005) 2.71
The primary health care non-team. BMJ (1994) 2.66
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65
A comparison of reinforcer assessment methods: the utility of verbal and pictorial choice procedures. J Appl Behav Anal (1996) 2.63
Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging (1995) 2.62
Pneumococcal bacteraemia in two immunocompetent adults with otitis media and bronchitis. Lancet (1990) 2.59
Health-related behaviour in context: a multilevel modelling approach. Soc Sci Med (1996) 2.57
Insulin coma therapy in schizophrenia. J R Soc Med (2000) 2.49
Integrating pharmacy fully into the primary care team. BMJ (1995) 2.47
Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet (1975) 2.46
Understanding the Italian Experience. Br J Psychiatry (1985) 2.41
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
Molecular technique for rapid identification of mycobacteria. J Clin Microbiol (1996) 2.37
Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther (2000) 2.34
Genetic diversity of Campylobacter jejuni isolates from farm animals and the farm environment. Appl Environ Microbiol (2003) 2.32
Do places matter? A multi-level analysis of regional variations in health-related behaviour in Britain. Soc Sci Med (1993) 2.30
Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet (2004) 2.29
Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol (2000) 2.27
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol (2000) 2.23
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A (2000) 2.23
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet (2000) 2.15
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA (1999) 2.14
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet (1994) 2.14
Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci. Am J Hum Genet (1992) 2.12
Asthma--still a challenge for general practice. J R Coll Gen Pract (1989) 2.08
Isolation of vero cytotoxin-producing Escherichia coli O157 from wild birds. J Appl Microbiol (1997) 2.08
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet (1999) 2.08
A double-blind comparison of quinine sulphate and placebo in muscle cramps. Age Ageing (1983) 2.07
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res (1997) 2.06
Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet (2000) 2.05
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol (2000) 2.05
The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. J Altern Complement Med (1998) 2.04
Properties and composition of the isolated ribosomal DNA satellite of Xenopus laevis. Nature (1968) 2.04
Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J Lipid Res (2001) 2.02
PTEN mutations in gliomas and glioneuronal tumors. Oncogene (1998) 2.01
Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet (1996) 2.01
Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate. Am J Hum Genet (1991) 1.98
Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene (1998) 1.97
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet (2004) 1.96
The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II. J Altern Complement Med (1998) 1.91
PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet (2001) 1.87
Cattle and sheep farms as reservoirs of Campylobacter. J Appl Microbiol (2003) 1.86
Molecular characterisation of a common SDHB deletion in paraganglioma patients. J Med Genet (2007) 1.86
Rescue of the Drosophila phototransduction mutation trp by germline transformation. Science (1985) 1.85
PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res (1999) 1.85
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet (2000) 1.84
Molecular identification of latent precancers in histologically normal endometrium. Cancer Res (2001) 1.84
A new route to spirooxindoles. Org Lett (2000) 1.84
Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. JAMA (1995) 1.83
Predicting small-area health-related behaviour: a comparison of smoking and drinking indicators. Soc Sci Med (2000) 1.82
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol (2001) 1.82
Interpretation of trauma radiographs by junior doctors in accident and emergency departments: a cause for concern? J Accid Emerg Med (1997) 1.81
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Vacuum blotting enhances nucleic acid transfer. Trends Genet (1988) 1.80
The rapid resolution of naturally occurring amino acids by thin-layer chromatography. J Chromatogr (1966) 1.78
Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res (2000) 1.78
Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology (1997) 1.75
Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol (2001) 1.71
A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate. J Appl Behav Anal (1997) 1.69
PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum Mol Genet (2001) 1.69
The seasonal variation of thermophilic campylobacters in beef cattle, dairy cattle and calves. J Appl Microbiol (1998) 1.68
Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet (1995) 1.68
Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet (1992) 1.68
Microbial contamination of fruit and vegetables and the behaviour of enteropathogens in the phyllosphere: a review. J Appl Microbiol (2007) 1.67
Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet (2001) 1.66
An epidemiological study of oral contraceptives and breast cancer. Br Med J (1979) 1.63
Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J Clin Endocrinol Metab (1998) 1.63
Localisation of cellular globin messenger RNA by in situ hybridisation to complementary DNA. FEBS Lett (1973) 1.63
Germline SDHD mutation in familial phaeochromocytoma. Lancet (2001) 1.62